Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples